Mirae Asset Global Investments’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.5K Buy
4,001
+537
+16% +$5.04K ﹤0.01% 1301
2025
Q1
$28K Buy
3,464
+70
+2% +$565 ﹤0.01% 1343
2024
Q4
$40.6K Sell
3,394
-280
-8% -$3.35K ﹤0.01% 1299
2024
Q3
$77.2K Buy
3,674
+794
+28% +$16.7K ﹤0.01% 1228
2024
Q2
$66.8K Sell
2,880
-214,514
-99% -$4.97M ﹤0.01% 1193
2024
Q1
$7.73M Buy
217,394
+31,536
+17% +$1.12M 0.02% 743
2023
Q4
$5.67M Sell
185,858
-100,885
-35% -$3.08M 0.01% 852
2023
Q3
$9.07M Buy
286,743
+22,633
+9% +$716K 0.02% 650
2023
Q2
$10.8M Buy
264,110
+46,381
+21% +$1.89M 0.02% 615
2023
Q1
$8.11M Buy
217,729
+9,458
+5% +$353K 0.02% 717
2022
Q4
$7.27M Sell
208,271
-3,152
-1% -$110K 0.02% 706
2022
Q3
$11.8M Buy
211,423
+31,898
+18% +$1.78M 0.03% 520
2022
Q2
$9.29M Buy
179,525
+103,651
+137% +$5.36M 0.02% 623
2022
Q1
$5.51M Sell
75,874
-13,707
-15% -$996K 0.01% 840
2021
Q4
$10.6M Sell
89,581
-49,434
-36% -$5.85M 0.02% 668
2021
Q3
$18.6M Buy
139,015
+26,113
+23% +$3.5M 0.05% 429
2021
Q2
$18.3M Buy
112,902
+1,604
+1% +$260K 0.05% 422
2021
Q1
$8.93M Buy
111,298
+50,496
+83% +$4.05M 0.03% 559
2020
Q4
$3.31M Buy
60,802
+23,700
+64% +$1.29M 0.01% 765
2020
Q3
$738K Buy
37,102
+11,795
+47% +$235K ﹤0.01% 1072
2020
Q2
$532K Buy
25,307
+9,651
+62% +$203K ﹤0.01% 1117
2020
Q1
$191K Buy
15,656
+1,702
+12% +$20.8K ﹤0.01% 1323
2019
Q4
$205K Buy
13,954
+3,407
+32% +$50.1K ﹤0.01% 1436
2019
Q3
$141K Buy
+10,547
New +$141K ﹤0.01% 1396